Planning Strategies Inc.’s Eledon Pharmaceuticals ELDN Stock Holding History

Planning Strategies Inc.’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$713	Buy	+181	New	+$658	﹤0.01%	800

Other funds holding ELDN

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

PW Nova Financial Services Newtown, Pennsylvania $466M AUM

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

Planning Strategies Inc.'s ELDN Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 181 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #800 among its holdings.

38 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Planning Strategies Inc. held 181 shares of Eledon Pharmaceuticals worth $713 as of Q2 2026.
Eledon Pharmaceuticals was a new Planning Strategies Inc. position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #800 holding.
38 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.